PharmaLytica 2022
Exhibition

PharmaLytica 2022

01.06.2022 - 03.06.2022 Mumbai, India, Nesco Center
Hotels near Hotels near
Visit the official Organizer website to ensure the accuracy of the event
Category: Medical & Pharma, Pharmaceuticals
Organizer: Informa Markets
Exhibition center: Nesco Center

Overview interest facts - PharmaLytica 2022

PharmaLytica 2022 is geared to further create business opportunities and tap the lucrative market in analytical, lab equipment, pharma machinery and packaging market in India. The event aims to deepen understanding of the changing landscape in the sector to enable responses to marketplace trends and towards establishing a unique drug safety ecosystem in India.

Overview of exhibitors / visitors - PharmaLytica 2022

Analytical and Bio Tech: Analytical instruments and systems, instruments for physical and chemical analysis, biochemicals, bioinformatics, medicine and diagnostics, life sciences, material testing, QA & QC, chromatographs, spectroscopes, microscopes and imaging, REGULATORY SERVICES, HPLC & UHPLC COLUMNS. Lab Equipments & Lab Chemicals: Lab equipments, cleanrooms, lab furniture & glassware, lab chemicals, consumables, reagents, ANALYSERS, water technology. Pharma Machinery: innovative pharmaceutical machinery, equipment and technology focusing on new developments. Outsourcing Solutions: Contract services that include contract research, contract / custom manufacturing & clinical trials


News

​AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan

A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...

22 January 2024
​New material improves treatment of complex bone infections

Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...

29 November 2023
Sepsis - as common as cancer, as deadly as a heart attack

In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.

04 September 2023
​FDA approves first oral treatment for postpartum depression

Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.

10 August 2023
​New blood test finds two thirds of cancers

A new multi-cancer early detection blood test could speed up diagnosis.

16 June 2023
​EU Proposes Drug Manufacturing Overhaul, Faces Pushback

The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws

04 May 2023
All news